Literature DB >> 1358562

Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways.

S Fiorucci1, R Bosso, A Morelli.   

Abstract

The effect of administering different doses of erythromycin on gallbladder emptying and plasma concentrations of immunoreactive motilin was investigated in healthy volunteers. Erythromycin was infused for 30 min at four different doses: 20, 50, 100, and 1000 mg/hr. Gallbladder volume was determined by ultrasound scanning every 10 min for 60 min. All doses, except 20 mg/hr, provoked a significant reduction in gallbladder volume (P < 0.01). The gallbladder emptying peak occurred after 20 min infusion. It was approximately 40-45% of basal volume and 60-70% of the emptying observed after a standard meal. At 100 mg/hr, erythromycin caused a 2.5-fold increase in plasma motilin concentration, which reached a peak after 30 min infusion. Plasma motilin peaked following maximum gallbladder emptying in all subjects. To evaluate whether cholinergic pathways were implicated in the action of erythromycin, 100 mg/hr erythromycin was infused together with 6 micrograms/kg/hr atropine. Atropine inhibited both gallbladder emptying and motilin release (P < 0.001). Infusion of 1 microgram/kg/hr somatostatin had the same inhibitory effects (P < 0.001). Our results suggest that atropine acts by inhibiting an erythromycin-activated cholinergic neural mechanism. Somatostatin could exert its inhibitory effect by blocking the release of acetylcholine from neural terminations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358562     DOI: 10.1007/bf01299858

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

Review 1.  Cyclic motor activity; migrating motor complex: 1985.

Authors:  S K Sarna
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

2.  Sonographic measurement of gallbladder volume.

Authors:  W J Dodds; W J Groh; R M Darweesh; T L Lawson; S M Kishk; M K Kern
Journal:  AJR Am J Roentgenol       Date:  1985-11       Impact factor: 3.959

Review 3.  Somatostatin.

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

4.  Gastrointestinal motor effects of erythromycin.

Authors:  M F Otterson; S K Sarna
Journal:  Am J Physiol       Date:  1990-09

5.  EM-523, an erythromycin derivative, and motilin show similar contractile activity in isolated rabbit intestine.

Authors:  T Satoh; N Inatomi; H Satoh; S Marui; Z Itoh; S Omura
Journal:  J Pharmacol Exp Ther       Date:  1990-09       Impact factor: 4.030

6.  Changes in plasma motilin concentration and gastrointestinal contractile activity in conscious dogs.

Authors:  Z Itoh; S Takeuchi; I Aizawa; K Mori; T Taminato; Y Seino; H Imura; N Yanaihara
Journal:  Am J Dig Dis       Date:  1978-10

7.  Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog.

Authors:  Z Itoh; M Nakaya; T Suzuki; H Arai; K Wakabayashi
Journal:  Am J Physiol       Date:  1984-12

8.  In vitro effects of pancreatic polypeptide and motilin on contractility of human gallbladder.

Authors:  I S Pomeranz; J S Davison; E A Shaffer
Journal:  Dig Dis Sci       Date:  1983-06       Impact factor: 3.199

9.  Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus.

Authors:  R Guillemin
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

10.  Periodic contractions of the canine gallbladder during the interdigestive state.

Authors:  Z Itoh; I Takahashi
Journal:  Am J Physiol       Date:  1981-02
View more
  10 in total

1.  Gallbladder fasting volume is reduced and gallbladder postprandial emptying is enhanced by intravenous erythromycin.

Authors:  I Tsiaoussis; E Xynos; G Tzovaras; E Chrysos; M Glynos; J S Vassilakis
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

Review 2.  Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures.

Authors:  J R Malagelada; E Distrutti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

3.  Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs.

Authors:  T Tanaka; A Mizumoto; E Mochiki; H Suzuki; Z Itoh; S Omura
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

4.  Effect of single dose of oral erythromycin on gastric and gallbladder emptying. Simultaneous assessment by ultrasound.

Authors:  V Arienti; F Magri; L Boriani; G Maconi; L Bassein; M Baraldini; L Marzio; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

5.  Direct inhibitory effect of erythromycin on the gallbladder muscle.

Authors:  A Nissan; Y Mashriki; J M Zhang; Y Haskel; H R Freund; M Hanani
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

6.  Motilin induces gall bladder emptying and antral contractions in the fasted state in humans.

Authors:  Y C Luiking; T L Peeters; M F Stolk; V B Nieuwenhuijs; P Portincasa; I Depoortere; G P van Berge Henegouwen; L M Akkermans
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

7.  5-hydroxytryptamine 3-receptor antagonist modulates gallbladder emptying and motilin release induced by erythromycin.

Authors:  S Fiorucci; L Santucci; A Morelli
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

8.  Gastrointestinal defects in gallstone and cholecystectomized patients.

Authors:  Agostino Di Ciaula; Emilio Molina-Molina; Leonilde Bonfrate; David Q-H Wang; Dan L Dumitrascu; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2019-01-29       Impact factor: 4.686

9.  L-arginine/nitric oxide pathway modulates gastric motility and gallbladder emptying induced by erythromycin and liquid meal in humans.

Authors:  S Fiorucci; E Distrutti; A Quintieri; L Sarpi; Z Spirchez; N Gulla; A Morelli
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

10.  Erythromycin as an alternative to reduce interfering extra-cardiac activity in myocardial perfusion imaging.

Authors:  M Vorster; M M Sathekge; P Rheeder
Journal:  Cardiovasc J Afr       Date:  2010 May-Jun       Impact factor: 1.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.